|
M
Mon
|
T
Tue
|
W
Wed
|
T
Thu
|
F
Fri
|
S
Sat
|
S
Sun
|
|---|---|---|---|---|---|---|
|
0 events,
|
1 event,
-
Some human studies may be unfeasible or unethical, making cross-species research critical for drug discovery and biomarker validation. Cross-species research is a crucial method to collect data to examine potential toxicity for a candidate drug, determine the efficacious doses that may be suitable for humans, identify potential biomarkers for a disease of interest or a […] |
1 event,
-
In this training, we’ll introduce how you can analyze and interpret your phosphoproteomics data in QIAGEN IPA. Using an example phosphoproteomics dataset, we will answer questions such as: • How can I format the data before uploading it into QIAGEN IPA? • How do I set up the analysis? • Which upstream kinases are implicated […] |
2 events,
-
Rejoignez-nous le 28 septembre pour découvrir comment HGMD Pro (Human Gene Mutation Database Professional) peut rationaliser vos recherches et analyses génétiques à travers diverses approches NGS. HGMD est une base de données de référence avec des mesures expertes de conservation et de contrôle de la qualité pour garantir l'exactitude et la fiabilité de ces données. […]
-
En este seminario web, usuarios de QIAGEN IPA mostrarán cómo les ha ayudado en su investigación nuestro software de análisis e interpretación de datos de expresión génica. Los principales temas tratados serán: • Aplicaciones de QIAGEN IPA en Biología de la Reproducción • Aplicaciones de QIAGEN IPA en la simulación de vías de transducción […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
2 events,
-
If you’re working in pharma or biotech, you likely rely on artificial intelligence (AI) to help you identify new drug targets or plausible biomarkers for disease within large data sets. Yet AI alone isn't enough. A large proportion of Biomedical data have errors and are unstructured. For AI models to provide reliable insights, the underlying […]
-
If you’re working in pharma or biotech, you likely rely on artificial intelligence (AI) to help you identify new drug targets or plausible biomarkers for disease within large data sets. Yet AI alone isn't enough. A large proportion of Biomedical data have errors and are unstructured. For AI models to provide reliable insights, the underlying […] |
2 events,
-
In this training, we will introduce you to QIAGEN CLC Genomics Workbench, including a live demo of the basic features and main functionalities. During the training, we’ll cover: • A general overview of the Workbench user interface • Easy installation on Windows, Mac and Linux • Plugin installation, e.g., Biomedical Genomics Analysis plugin • Reference […]
-
Join us for a 120-minute training session for new users of QIAGEN IPA. In this training, you’ll learn how to: • Upload your dataset (RNA-seq, scRNA-seq, proteomics, metabolomics and more) and perform interactive core/pathway analysis in IPA • Understand the different result types produced (pathways, key regulators, impact on biological functions/diseases and more) • Compare […] |
2 events,
-
Circulating tumor cells (CTCs) are cells that leave the primary tumor and are intravasated into the blood circulation system. A subset of those make it to other organs and are responsible for metastasis. iCellate’s CellMate platform is a CTC-based liquid biopsy for cancer cell enrichment, detection, and biomarker analysis via a simple blood draw. In this […]
-
Scale your NGS analysis to match your sequencing throughput using our QIAGEN CLC Genomics cloud solution. In this webinar, you’ll learn about the flexible and powerful setup for running your NGS sequence analyses on Amazon Web Services (AWS). You’ll learn how to use QIAGEN CLC Genomics Workbench to customize workflows and send analyses to AWS […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
Biomedical relationships knowledge is now required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many more applications. In this one-hour training, you’ll get an introduction to QIAGEN Biomedical Knowledge Base. You’ll learn how to tackle applications you can’t achieve with the QIAGEN Ingenuity Pathway […] |
0 events,
|
2 events,
-
Clinical exome sequencing (CES) is increasingly being adopted by small and mid-sized laboratories to diagnose genetic diseases, aid treatment decisions, and provide prognostic information. However, the exponential increase in genetic data generated from exome and genome panels poses significant workflow challenges. The ability to prioritize potentially pathogenic variants from large datasets and identify the few […]
-
Cancer outcome is influenced by both the tumor microenvironment and host immune response. Using QIAGEN OmicSoft Studio to access public data from The Cancer Genome Atlas (TCGA) and our human Single Cell Lands collection, you’ll learn how to: • View host immune response clusters across TCGA samples • Identify differentially expressed immunomodulators across sample groups […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
2 events,
-
This webinar is for data scientists and bioinformaticians working in biopharma who need extensive high-quality omics data for target discovery efforts. Learn how to programmatically discover, retrieve, filter, aggregate, and analyze omics data from QIAGEN’s extensive repositories of deeply-curated multi-omics data. Attendees will learn how to leverage extensive metadata to find and combine datasets of […]
-
This 120-minute training will teach you how to easily analyze and interpret RNA-seq data using QIAGEN CLC Genomics Workbench software and QIAGEN Ingenuity Pathway Analysis (IPA). For RNA-seq data, you will learn how to: • Import FASTQ files, cell matrix files and metadata and how to download references • Map reads to a reference genome […] |
0 events,
|
1 event,
-
In its latest release, QCI Interpret for Hereditary extends its market-leading content with further advancements in Artificial Intelligence (AI) for enhanced capabilities in clinical exome NGS testing. Now, with the addition of AI-derived literature references for rare disease genes, QCI Interpret provides complete exome coverage, on top of the existing unrivalled manually curated content and […] |
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
This 90-minute training session is about how QIAGEN Ingenuity Pathway Analysis (IPA) allows visualization of molecular intricacy and variations at multiple levels such as transcriptome, proteome, and metabolome. Through a series of brief technical vignettes, it is demonstrated how to: · Generate associations among molecular signatures obtained via integrating multi-omics data · Extract mechanisms from […] |
3 events,
-
Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to […]
-
Interested in learning about new features and functionalities that have been added to IPA lately? During this webinar, we will highlight the updates from the QIAGEN IPA Fall Release and from previous releases from this year. Topics, amongst others, will be • Newly added findings and pathways • Reactome pathways • Artificial intelligence approves to […]
-
Clinical metagenomic next-generation sequencing (mNGS), the comprehensive analysis of microbial and host DNA and RNA in samples from patients, is rapidly moving from research to clinical laboratories. This emerging approach is changing the diagnosis and treatment of diseases, with applications in a range of areas, including oncology, human host gene expression (transcriptomics), and antimicrobial infections […] |
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
2 events,
This year at the American Society for Human Genetics (ASHG) 2023 Annual Meeting, QIAGEN will be showcasing our Sample to Insight solutions for human genetics at booth #902. Learn more about our products and solutions and receive complimentary demos of our bioinformatic software and databases. Our experts will be available to chat with you and […]
-
In this webinar, we will introduce how to analyze and explore your QIAseq miRNA data in RNA-seq Analysis Portal. During the webinar, we will answer the following questions: • Which sample kits are supported by RNA-seq Analysis Portal? • How to upload your data to RNA-seq Analysis Portal? • How to start an analysis? • […] |
2 events,
-
The responsibility of fertility is disproportionately placed on women, who bear most of the health, emotional and financial burdens. Infertility is rapidly rising, with one in six Australian couples seeking assisted reproductive technologies to help them start a family, and over 50% of cases involving a male factor. Despite these contributions, we still don’t fully […] |
1 event,
|
1 event,
|
1 event,
|
Industry leaders discuss how to improve the speed, precision and cost-effectiveness of clinical exome testing for newborn screening and rare and undiagnosed diseases Clinical exome testing is revolutionizing the diagnosis of rare and inherited diseases. Its ability to quickly pinpoint the genetic causes of complex conditions has made it a critical component of personalized medicine, […]
Watch NowIn this training, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example, but similar analysis can be done with other viral and microbial (bacteria, fungus and more) samples. Using viral samples, you will learn how to: […]
Watch NowMore and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS), depending on user preference. We will demonstrate how CLC Genomics […]
Watch NowThere is a strong interest in the scientific community to use public (GEO, SRA, TCGA, LINCS, etc.) omics (RNA-seq, scRNA-seq, microarray, proteomics, etc.) data for a variety of discoveries. This webinar, aimed at data scientists, bioinformaticians and similar roles in biopharma and academia, explores a comprehensive way of accessing and analyzing high-quality, expertly curated omics […]
Watch NowYou’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology […]
Watch NowIngenuity Pathway Analysis (IPA), currently cited in tens of thousands of publications and used by a large number of biopharmaceutical companies, is backed by QIAGEN Biomedical KB-HD. Accordingly, biomedical relationships knowledge has practically become required for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis, artificial intelligence (AI)-driven target identification and many […]
Watch Now
